Clinical Trial Update: Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia

View source ↗

Summary

A completed centralised Pan-Algerian survey evaluating undertreatment of hypercholesterolemia and related cardiovascular conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Heart Disease
• Diabetes
• Hypercholesterolemia
• Hypertension
• Peripheral Arterial Disease

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesterolemia, Cardiovascular Disease | Status: COMPLETED